← Alle mensen

RH

R Haddad

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Durvalumab-tremelimumab versus EXTREME bij recidief hoofd-halscarcinoom: KESTREL definitief

Annals of oncology : official journal of the European Society for Medical Oncology · 2023-03

Durvalumab met of zonder tremelimumab bij recidief hoofd-halscarcinoom: KESTREL fase III

Annals of oncology : official journal of the European Society for Medical Oncology · 2020-07